Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Understanding Hyperhidrosis: Diagnosis, Classification, and Treatment
Description
The presentation focuses on hyperhidrosis, characterized by excessive sweating that exceeds normal thermal regulation. Hyperhidrosis is classified as primary or secondary, with primary hyperhidrosis lacking an identifiable external cause and potentially having a familial link, affecting individuals predominantly between ages 14 and 25. Diagnostic criteria include persistent visible sweating, a negative secondary cause, and specific symptomatic classifications. Prevalence ranges from 0.6% to 4.4%, with subjective reports indicating up to 20%. The severity can be measured through the Hyperhidrosis Disease Severity Scale, ranging from sweat that is barely noticeable to intolerable. Secondary hyperhidrosis arises from underlying conditions or medications and can be classified by distribution (generalized or focal) and neural impulses. Common causes include infections, malignancies, and endocrine disorders. Treatment for hyperhidrosis often necessitates a holistic approach to mitigate associated stigmas and encourage individuals to seek help. This includes educating healthcare providers and patients about the condition to improve management strategies and outcomes.
View moreConclusions
- Hyperhidrosis is excessive sweating beyond normal thermoregulation requirements.
- Primary hyperhidrosis is often familial and has no identifiable secondary cause, with about 34% to 62% of cases having a positive family history.
- The age of onset for primary hyperhidrosis typically ranges between 14 and 25 years, though regression can occur over time.
- Diagnostic criteria for primary hyperhidrosis include excessive, visible sweating for at least six months and at least two additional characteristics such as bilateral symmetry and a positive family history.
- The prevalence of hyperhidrosis is estimated to be between 0.6% and 4.4%, although subjective evaluations may reach up to 20%.
- A genetic predisposition appears to be present, with inheritance mechanisms possibly being autosomal dominant or recessive in nature.
- Patients with generalized hyperhidrosis often have comorbidities such as obesity, depression, and anxiety, significantly impacting their quality of life.
- Hyperhidrosis negatively affects daily activities and can lead to social anxiety, embarrassment, and reduced professional efficacy due to fear of sweating.
- There is a concerning association between hyperhidrosis and an increased risk of skin infections, warranting attention from clinicians.
- Secondary hyperhidrosis can stem from underlying conditions or as a side effect of medications, requiring careful evaluation of the causes.
- Treatment for hyperhidrosis is essential to improve patients' quality of life, and a holistic approach to care can help reduce stigma and improve understanding among healthcare professionals.
- Multi-specialty Working Group on Recognition, Diagnosis, and Treatment of Primary Focal Hyperhidrosis, 2003.
- Archives of Dermatological Research (2019) 311:735-740
- J Bras Pneumol. 2018;44(4):292-298
- J Am Acad Dermatol. 2019 Aug;81(2):624-627
- StatPearls Publishing; 2022 Jan -
- Postepy Dermatol Alergol. 2020;37:700-704.
- Acta Derm Venereol. 2021;101(4).
- PLoS One. 2019;14(9);e0220664.
- Dermatol Surg. 2007; 33(8):908-923.
- Acta Derm Venereol 2022 S-L. Heiskanen et al.
- JOURNAL OF DERMATOLOGICAL TREATMENT 2021
- Something to Sweat About: Two Cases of Dupilumab-Induced Hyperhidrosis and Bromhidrosis. Allergy Rhinol (Providence). 2020
- Shayesteh, A., Gerdsdorff, F., Persson, M., Brulin, C., & Nylander, E. (2021). Navigating in the fog. Facing delays, rejection and ignorance when seeking help for primary hyperhidrosis. INTERNATIONAL JOURNAL OF QUALITATIVE STUDIES ON HEALTH AND WELL-BEING.